SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-065202
Filing Date
2024-05-28
Accepted
2024-05-28 16:14:56
Documents
2
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1561
2 EX-24 crsp-ex24.htm EX-24 15897
  Complete submission text file 0000950170-24-065202.txt   18868
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CRISPR THERAPEUTICS 105 WEST FIRST STREET BOSTON MA 02127
Business Address
Patel Naimish (Reporting) CIK: 0002021679 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 24991976